Loading data for DNA — first visit, this takes a few seconds.
Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA
· 即時價格 · USD
6.96
-0.30 (-4.13%)
收盤價： Aug 28, 2026, 8:00 PM
股價、關鍵數字和最新消息，都在這一頁。
Ginkgo Bioworks Holdings, Inc.（DNA）股價、分析與資料
無可用資料
| 買價 | 6.95 |
| 市值 | 469M |
| 營收 (ttm) | 132M |
| 淨利（ttm） | -310M |
| 1.79 | |
| -5.33 | |
| n/a | |
| -2.4 | |
| P/B (ttm) | 1.06 |
| P/S (ttm) | 3.54 |
| 財報日期 | Nov 5, 2026 |
| 賣價 | 6.96 |
| 成交量 | 1,261,803 |
| 20 日平均成交量 | 1,188,366 |
| 開盤價 | 7.23 |
| 前收盤價 | 7.26 |
| 當日區間 | 6.92 - 7.29 |
| 52 週範圍 | 5.37 - 17.58 |
| 分析師 | n/a |
| 目標價 | n/a |
| 股利 | n/a |
| 除息日 | n/a |
關於 DNA
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell engineering in the United States. It operates through the Cell Engineering and Biosecurity segments. The company offers cell engineering research and development solutions, as well as cell engineering tools comprising functional genomics, antibody developability, and small molecule developability, artificial intelligence models, and reconfigurable automat...
完整的公司簡介財務表現
Ginkgo Bioworks s 在 2025 年的營收為 170.16M，較前一年的 227.04M 減少 -25.06%。 淨利為 -312.76M，較前期減少 -42.83%。
財務報表財報驚奇
Ginkgo Bioworks s 已於 Aug 5, 2026 公布季度財報：
- 營收為 $20.16M 低於預期 $0, 年增 -48.49% 下滑.
- 每股盈餘為 -0.73 低於預期 -0.03, 年增 33.64% 成長.
第 1 頁，共 2 頁